CytoSorbents Updates on DrugSorb-ATR Regulatory Developments Following FDA Denial CytoSorbents provides an important regulatory update on DrugSorb-ATR, aiming to address severe bleeding during cardiac surgeries. FDA engagement continues.

CytoSorbents Updates on DrugSorb-ATR Regulatory Developments Following FDA Denial #United_States #Princeton #CytoSorbents #DrugSorb-ATR #FDA_Denial